Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?

JAMA psychiatry·2020

Same author

Reply to: Say What?! Ableist Logic Used in Misguided Attempt to Combat Ageism During COVID-19.

Journal of the American Geriatrics Society·2020

Same author

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy.

Journal of psychiatry & neuroscience : JPN·2020

Same author

Insomnia subtypes and clinical impairment in hospitalized children with autism spectrum disorder.

Autism : the international journal of research and practice·2020

Same author

The Effect of Venlafaxine on Electrocardiogram Intervals During Treatment for Depression in Older Adults.

Journal of clinical psychopharmacology·2020

Same author

Telomere length and its relationships with lifestyle and behavioural factors: variations by sex and race/ethnicity.

Age and ageing·2020

Search research articles

Related Experiment Video

Updated: Feb 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Exercise effects on depression: Possible neural mechanisms.

Swathi Gujral¹, Howard Aizenstein², Charles F Reynolds²

¹University of Pittsburgh, Department of Psychology, United States; Center for Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh, United States.

General Hospital Psychiatry

|November 11, 2017

Summary

This summary is machine-generated.

Exercise may improve depression by targeting specific brain structures. This review highlights the prefrontal cortex, hippocampus, and corpus callosum as key areas affected by both depression and exercise.

Keywords:

Depression Exercise Gray matter MRI White matter

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Related Experiment Videos

Last Updated: Feb 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Animal Models of Depression - Chronic Despair Model CDM

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Area of Science:

Neuroscience
Psychiatry
Exercise Science

Background:

Depression involves stress and emotion dysregulation, linked to structural changes in frontal-limbic brain networks.
Volumetric reductions in the hippocampus, anterior cingulate cortex, prefrontal cortex, striatum, and amygdala are common in depressed adults.
White matter integrity is also compromised in individuals with depression.

Purpose of the Study:

To review the overlap between structural brain abnormalities in depression and exercise's effects on brain structure.
To identify potential neural mechanisms mediating exercise's positive impact on depressive symptoms.
To highlight specific brain regions as potential targets for exercise interventions.

Main Methods:

Systematic review of existing literature.
Examination of meta-analytic evidence on structural brain changes in depression.
Analysis of studies investigating the effects of exercise on brain structure in adults.

Main Results:

The prefrontal cortex, anterior cingulate cortex, hippocampus, and corpus callosum were identified as key structural neural markers.
These regions show abnormalities in depression and are affected by exercise.
These findings suggest potential neurobiological pathways for exercise's antidepressant effects.

Conclusions:

The prefrontal cortex, anterior cingulate cortex, hippocampus, and corpus callosum may serve as targets for exercise-based depression treatments.
Further research is needed to confirm these mechanisms.
Randomized exercise interventions are crucial to test these proposed neurobiological effects.